| # | Drug | Count |
|---|---|---|
| 0 | EFAVIRENZ | 39 |
| 1 | LAMIVUDINE | 33 |
| 2 | LAMIVUDINE ORAL | 33 |
| 3 | DARUNAVIR | 26 |
| 4 | ZIDOVUDINE | 23 |
| 5 | RITONAVIR | 22 |
| 6 | RALTEGRAVIR | 21 |
| 7 | DARUNAVIR 600 MG | 20 |
| 8 | DARUNAVIR 800 MG | 20 |
| 9 | EMTRICITABINE | 17 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RALTEGRAVIR | 21 | 0.0040 |
| 1 | EFAVIRENZ | 39 | 0.0035 |
| 2 | DARUNAVIR 600 MG | 20 | 0.0032 |
| 3 | DORAVIRINE, LAMIVUDINE, AND TENOFOVIR DISOPROXIL FUMARATE | 1 | 0.0032 |
| 4 | ZIDOVUDINE | 23 | 0.0022 |
| 5 | MARAVIROC | 5 | 0.0022 |
| 6 | DESFLURANE | 3 | 0.0017 |
| 7 | DARUNAVIR | 26 | 0.0017 |
| 8 | NELFINAVIR MESYLATE | 3 | 0.0014 |
| 9 | ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE | 9 | 0.0014 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CCR5 Co-receptor Antagonist [EPC] | 5 | 0.0022 |
| 1 | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 48 | 0.0020 |
| 2 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 46 | 0.0009 |
| 3 | Protease Inhibitor [EPC] | 35 | 0.0008 |
| 4 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 68 | 0.0006 |
| 5 | Cytochrome P450 3A Inhibitor [EPC] | 29 | 0.0005 |
| 6 | Recombinant Human Growth Hormone [EPC] | 2 | 0.0001 |
| 7 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 8 | General Anesthetic [EPC] | 3 | 0.0001 |
| 9 | Antimycobacterial [EPC] | 1 | 0.0000 |